Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Theaflavin, a black tea polyphenol, protects nigral dopaminergic neurons against chronic MPTP/probenecid induced Parkinson's disease.
Anandhan A, Tamilselvam K, Radhiga T, Rao S, Essa MM, Manivasagam T.
Brain Res. 2012 Jan 18;1433:104-13. Epub 2011 Nov 13.
Related citations
Molecular pathogenesis of Parkinson's disease: update.
Saiki S, Sato S, Hattori N.
J Neurol Neurosurg Psychiatry. 2012 Apr;83(4):430-6. Epub 2011 Dec 3. Review.
Parkinson disease: Twin study identifies an association between exposure to a solvent and risk of Parkinson disease.
Kingwell K.
Nat Rev Neurol. 2011 Dec 6;8(1):2. doi: 10.1038/nrneurol.2011.194. No abstract available.
Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial.
Foley PB.
Neurology. 2011 Dec 6;77(23):e140; author reply e140. No abstract available.
Mood and motor trajectories in Parkinson's disease: multivariate latent growth curve modeling.
Zahodne LB, Marsiske M, Okun MS, Rodriguez RL, Malaty I, Bowers D.
Neuropsychology. 2012 Jan;26(1):71-80. Epub 2011 Dec 5.
Effects of noradrenaline and serotonin depletions on the neuronal activity of globus pallidus and substantia nigra pars reticulata in experimental parkinsonism.
Delaville C, Navailles S, Benazzouz A.
Neuroscience. 2012 Jan 27;202:424-33. Epub 2011 Nov 25.
FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models.
Bao XQ, Kong XC, Qian C, Zhang D.
Neuroscience. 2012 Jan 27;202:396-404. Epub 2011 Nov 25.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on